WATSON 409 (Lisinopril 40 mg)

Pill imprint WATSON 409 has been identified as Lisinopril 40 mg.

Lisinopril is used in the treatment of high blood pressure; diabetic kidney disease; migraine prevention; alport syndrome; coronary artery disease (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 40 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WATSON 409

Lisinopril 40 mg WATSON 409
Lisinopril 40 mg WATSON 409
Lisinopril 40 mg WATSON 409
Lisinopril
Imprint:
WATSON 409
Strength:
40 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-0409
Inactive Ingredients:
silicon dioxide
calcium phosphate dihydrate dibasic
magnesium stearate
mannitol
corn starch
FD&C Yellow No. 5
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-4646 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)